• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿透性角膜移植术联合丝裂霉素C小梁切除术治疗并存的角膜疾病和青光眼

Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.

作者信息

Figueiredo R S, Araujo S V, Cohen E J, Rapuano C J, Katz L J, Wilson R P

机构信息

Cornea Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Ophthalmic Surg Lasers. 1996 Nov;27(11):903-9.

PMID:8938797
Abstract

BACKGROUND AND OBJECTIVE

The management of coexistent corneal disease and uncontrolled glaucoma continues to be a challenging clinical situation. The purpose of this study is to evaluate the results of combined penetrating keratoplasty and trabeculectomy with mitomycin-C.

PATIENTS AND METHODS

A retrospective study was undertaken to review the records of nine patients who had corneal edema and high intraocular pressure managed by simultaneous penetrating keratoplasty and trabeculectomy with mitomycin-C.

RESULTS

The nine patients had an average pre-operative intraocular pressure of 26 mm Hg (range 17 to 41 mm Hg) and associated corneal edema. The average postoperative intraocular pressure at last follow-up was 19 mm Hg (range 5 to 53 mm Hg). Three patients needed additional procedures. Six of nine patients had intraocular pressures judged to be adequately controlled (11 +/- 5 mm Hg, range 5 to 18 mm Hg) throughout the postoperative period (average follow-up 16 months). Grafts remained clear in seven patients. The grafts failed in two cases in which additional glaucoma surgery was necessary.

CONCLUSION

Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure.

摘要

背景与目的

并存角膜疾病和未控制的青光眼的治疗仍然是具有挑战性的临床情况。本研究的目的是评估穿透性角膜移植术联合丝裂霉素C小梁切除术的效果。

患者与方法

进行一项回顾性研究,以回顾9例因角膜水肿和高眼压而接受穿透性角膜移植术联合丝裂霉素C小梁切除术治疗的患者的记录。

结果

这9例患者术前平均眼压为26 mmHg(范围17至41 mmHg),伴有角膜水肿。末次随访时术后平均眼压为19 mmHg(范围5至53 mmHg)。3例患者需要额外的手术。9例患者中有6例在术后整个时期(平均随访16个月)眼压被判定得到充分控制(11±5 mmHg,范围5至18 mmHg)。7例患者的植片保持透明。2例患者的植片失败,需要进行额外的青光眼手术。

结论

对于患有未控制的青光眼和角膜疾病且有足够结膜用于滤过手术的特定患者,应考虑穿透性角膜移植术联合丝裂霉素C小梁切除术。

相似文献

1
Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.穿透性角膜移植术联合丝裂霉素C小梁切除术治疗并存的角膜疾病和青光眼
Ophthalmic Surg Lasers. 1996 Nov;27(11):903-9.
2
Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty.丝裂霉素C在小梁切除术联合或两阶段手术中的应用,随后进行穿透性角膜移植术。
J Glaucoma. 1999 Jun;8(3):184-7.
3
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.穿透性角膜移植术后难治性青光眼治疗中丝裂霉素C小梁切除术、青光眼引流装置植入术及激光钕:钇铝石榴石睫状体光凝术的比较
Ophthalmology. 1998 Aug;105(8):1550-6. doi: 10.1016/S0161-6420(98)98046-0.
4
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.穿透性角膜移植术联合丝裂霉素C小梁切除术
Ophthalmology. 1999 Feb;106(2):396-400. doi: 10.1016/S0161-6420(99)90081-7.
5
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.白内障超声乳化吸除联合人工晶状体植入及丝裂霉素C小梁切除术的中期随访结果
J Glaucoma. 1997 Apr;6(2):90-8.
6
Combined phacoemulsification and trabeculectomy with mitomycin-C.超声乳化白内障吸除术联合小梁切除术及丝裂霉素C
Ophthalmic Surg Lasers. 1997 Sep;28(9):739-44.
7
Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study.丝裂霉素C辅助小梁切除术治疗角膜移植术后青光眼:一项初步研究。
Ophthalmic Surg Lasers. 1997 Nov;28(11):891-5.
8
Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty.穿透性角膜移植术后撕囊全自动内皮角膜移植术的疗效比较。
Am J Ophthalmol. 2012 Jun;153(6):1091-8.e2. doi: 10.1016/j.ajo.2011.12.014. Epub 2012 Mar 6.
9
Intraoperative mitomycin-C for glaucoma associated with ocular inflammation.术中使用丝裂霉素C治疗与眼部炎症相关的青光眼。
Ophthalmic Surg Lasers. 1997 May;28(5):370-6.
10
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.白内障超声乳化吸除联合小梁切除术与单纯小梁切除术的比较研究:使用丝裂霉素C
Ophthalmic Surg Lasers. 1998 Sep;29(9):707-13.

引用本文的文献

1
Challenges in Managing Secondary Glaucoma Post-Repeat Penetrating Keratoplasty in a Developing Country.发展中国家重复穿透性角膜移植术后继发性青光眼的管理挑战
Int Med Case Rep J. 2023 Mar 18;16:179-185. doi: 10.2147/IMCRJ.S402944. eCollection 2023.
2
Comparison of long-term outcomes of trabeculectomy and risk factors for failure in eyes post penetrating keratoplasty or Descemet's stripping endothelial keratoplasty.穿透性角膜移植或撕囊内皮角膜移植术后小梁切除术的长期疗效比较及失败的危险因素。
Indian J Ophthalmol. 2022 Mar;70(3):827-833. doi: 10.4103/ijo.IJO_1213_21.
3
Glaucoma after penetrating keratoplasty.
穿透性角膜移植术后青光眼
Rom J Ophthalmol. 2017 Jul-Sep;61(3):159-165. doi: 10.22336/rjo.2017.30.
4
Post-penetrating keratoplasty glaucoma.穿透性角膜移植术后青光眼
Indian J Ophthalmol. 2008 Jul-Aug;56(4):269-77. doi: 10.4103/0301-4738.41410.
5
Graft failure: III. Glaucoma escalation after penetrating keratoplasty.移植失败:III. 穿透性角膜移植术后青光眼病情进展
Int Ophthalmol. 2008 Jun;28(3):191-207. doi: 10.1007/s10792-008-9223-5.